Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × Radiofrequency Ablation × Clear all

Phase

Phase 2 5 Phase 4 2 Phase NA 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 9 Liver Neoplasms 2 Thyroid Nodule 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms, Glandular and Epithelial 1 Hyperthyroidism 1 Hypertension, Portal 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 104 Leucovorin 97 Oxaliplatin 74 Bevacizumab 68 Irinotecan 57 Capecitabine 53 Cetuximab 34 Folfox protocol 27 Panitumumab 15 regorafenib 13 Drug Therapy 13 trifluridine tipiracil drug combination 12 Chemotherapy, Adjuvant 11 IFL protocol 9 Radiotherapy 8 Neoadjuvant Therapy 7 Floxuridine 7 Aspirin 6 pembrolizumab 5 XELOX 5 Levoleucovorin 5 Laparoscopy 5 dehydroftorafur 4 atezolizumab 4 Trifluridine 4 Octreotide 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4 xaliproden 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01233544 2016-05-12

RAS01

University of Aarhus

Phase 3 Terminated

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡